Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)

A legfontosabb adatok

Ki végzi
Adagio Medical
Hol
Belgium, Csehország, Franciaország, Hollandia, Kanada és Németország7 helyszín, 6 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
64 fő vett részt
Kezdés
2021. máj. 26.
Befejezés
2024. szept. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Ablation in the ventricles with the Adagio Medical VT Cryoablation System
A regiszteradat frissítve
2026. október 13.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 24 feltétel megnézéseKevesebb

Ki vehet részt

  • IC 1 Male or female the ages of ≥ 18 years
  • IC 2 Eligible for a catheter ablation due to Ischemic and/or non-ischemic recurrent symptomatic sustained monomorphic Ventricular Tachycardia also defined as having a similar QRS configuration from beat to beat
  • IC 3 Has or will be receiving an ICD prior to hospital discharge post procedure
  • IC 4 Refractory to at least one AAD (Refractory is defined as an AAD not able to treat the arrhythmia satisfactorily or induces unwanted side effects)
  • IC 5 Subject has LVEF > 20%, confirmed by echo or comparable technique in the previous 3 months or during baseline evaluation
  • IC 6 Willingness, ability, and commitment to participate in baseline and follow-up evaluations for the full length of the study
  • IC 7 Willingness and ability to give an informed consent

Ki nem vehet részt

  • EC 3 Any VT ablation within 4 weeks prior to enrollment
  • EC 4 More than one prior (>4 weeks) Ventricular Tachycardia ablation or prior surgical treatment for ventricular tachycardia
  • Previous cardiac surgery or percutaneous coronary intervention within 60 days prior to the procedure
  • Coronary artery bypass graft (CABG) procedure within six (6) months prior to the ablation procedure
  • Recent Myocardial Infarct (MI) or unstable angina, within 60 days prior to the ablation procedure
  • Mechanical aortic or mitral valve; EC 7 Any previous history of cryoglobulinemia; EC 8 History of blood clotting or bleeding disease; EC 9 Any prior history of documented cerebral vascular accident (CVA), TIA or systemic embolism (excluding a post-operative Deep Vein Thrombosis, DVT), within 6 months prior to the ablation procedure; EC 10 Breastfeeding, pregnant, or anticipated pregnancy during study follow-up; EC 11 Current enrollment in any other study protocol where testing or results from that study may interfere with the procedure or outcome measurements for this study; EC 12 Any other condition that, in the judgment of the investigator, makes the patient a poor candidate for this procedure, the study or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, candidate for heart transplantation, patient with ventricular assist device, or terminal illness with a life expectancy less than 12 months)
  • EC 1 Any known objective contraindication to ventricular tachycardia ablation, TEE, or anticoagulation, including but not limited to the identification of any cardiac thrombus or evidence of sepsis
  • EC 5 Ventricular tachycardia secondary to electrolyte imbalance, active thyroid disease, or any other reversible or non-cardiac cause
  • EC 6 Structural heart disease as described below:
  • Class IV heart failure
  • Severe Mitral or Aortic insufficiency or stenosis based on most recent TTE
  • Cardiac myxoma
  • EC 2 Any duration of continuous arrythmia that is not monomorphic ventricular tachycardia. Multiple monomorphic tachycardia is acceptable, but polymorphic VT is not
  • Aortic aneurysm
  • Interatrial baffle, closure device, patch, or PFO occlusion device
  • IVC filter
  • Significant congenital anomaly

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

6 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

A prospective, single-arm, multi-center, pre-market, clinical study designed to provide safety and performance data regarding the use of the Adagio Medical VT Cryoablation System in the treatment of ventricular tachycardia.

A vizsgálat csoportja

  • Ablation in the ventricle with the Adagio VT cryoablation systemA vizsgált kezelés

    all study subjects will receive an ablation procedure using the Adagio Medical VT Cryoablation System

    Kezelés: Ablation in the ventricles with the Adagio Medical VT Cryoablation System

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Cryoablation for Monomorphic Ventricular Tachycardia
Publikációk
A regiszteradat frissítve
2026. október 13.